Lonza Group Ltd - Company Profile
Powered by 
All the sales intelligence you need on Lonza Group Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Lonza Group Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Lonza Group Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Lonza Group Ltd (Lonza) is a contract manufacturing and development solutions company. It offers services including commercial mammalian and microbial manufacturing, clinical development, and manufacturing. The company also offers active pharmaceutical ingredients, cell and gene therapy capabilities, advanced intermediates, oral drug product development services, bioconjugates, mRNA, microbial, and cell and gene technologies, cell-culture modeling, genome editing, endotoxin products, and research media and testing products. The company collaborates with a diverse range of customers, including emerging biotechs and global pharmaceutical companies, to support clinical and commercial success. It serves biotechnology, pharmaceutical, academic, manufacturers of health and consumer products. The company has presence in Europe, Asia and America. Lonza is headquartered in Basel, Basel-Stadt, Switzerland.
Headquarters
Switzerland
Address
Muenchensteinerstrasse 38, Basel, Basel-Stadt, 4002
Website
www.lonza.com
No of Employees
16,866
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
LONN (SWF)
Revenue (2024)
$7.9B
19.2%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-143.2%
(2024 vs 2023)
Market Cap*
$50.9B
Net Profit Margin (2024)
XYZ
-136.3%
(2024 vs 2023)
* As of and is in US$
Lonza Group Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Biologics: | XS Technologies for Microbial Expression | Nucleofection |
| Mammalian | Quality Control Services | FlashGel System |
| Microbial | Contract Manufacturing | ProSieve |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In March, the company signed an agreement to sell Personalized Medicine business to Octane Medical Group. |
| 2026 | Corporate Changes/Expansions | In March, the company launched a Media Development Lab at its Singapore site. |
| 2026 | Contracts/Agreements | In March, the company extended its long-term manufacturing agreement with Genetix to expand ZYNTEGLO production in Houston. |
Competitor Comparison
| Key Parameters | Lonza Group Ltd | Novartis AG | Thermo Fisher Scientific Inc | GSK plc | Merck KGaA |
|---|---|---|---|---|---|
| Headquarters | Switzerland | Switzerland | United States of America | United Kingdom | Germany |
| City | Basel | Basel | Waltham | London | Darmstadt |
| State/Province | Basel-Stadt | Basel-Stadt | Massachusetts | England | Hessen |
| No. of Employees | 16,866 | 75,267 | 125,000 | 66,841 | 62,477 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Jean Marc Huet | Chairman | Executive Board | 2024 | 57 |
| Wolfgang Wienand | Chief Executive Officer | Senior Management | 2024 | 53 |
| Philippe Deecke | Chief Financial Officer | Senior Management | 2021 | 54 |
| Nicoleta Baumgartner | Chief Human Resources Officer | Senior Management | 2024 | 55 |
| Maria Soler Nunez | Chief Quality Officer | Senior Management | 2025 | 57 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer